Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular Perspective-Reference-Cited by-同舟云学术

Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular Perspective

Published:2002-02 Issue:2 Volume:46 Page:267-274
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Gillespie Stephen H.¹

Affiliation:

1. Royal Free and University College Medical School, University College London, London NW3 2PF, United Kingdom

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.46.2.267-274.2002

Reference86 articles.

1. Alland, D., G. E. Kalkut, A. R. Moss, R. A. McAdam, J. A. Hahn, W. Bosworth, E. Drucker, and B. R. Bloom. 1994. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N. Engl. J. Med.330:1710–1716.

2. Barnett, M., S. R. M. Bushby, and D. A. Mitchison. 1953. Tubercle bacilli resistant to isoniazid: virulence and response to treatment with isoniazid in guinea pigs and mice. Br. J. Exp. Pathol.34:568–581.

3. Bjorkman, J., D. Hughes, and D. I. Andersson. 1998. Virulence of antibiotic-resistant Salmonella typhimurium. Proc. Natl. Acad. Sci. USA95:3949–3953.

4. Bjorkman, J., I. Nagaev, O. G. Berg, D. Hughes, and D. I. Andersson. 2000. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science287:1479–1482.

5. Fitness of antibiotic-resistant microorganisms and compensatory mutations

Cited by 344 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLNNMDA: a multimodal prediction model for microbe-drug associations based on global and local features;Scientific Reports;2024-09-06

2. Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges;Expert Review of Anti-infective Therapy;2024-09-04

3. A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs;The International Journal of Tuberculosis and Lung Disease;2024-09-01

4. Breaking barriers: The potential of nanosystems in antituberculosis therapy;Bioactive Materials;2024-09

5. Recent Biochemical Advances in Antitubercular Drugs: Challenges and Future;Current Topics in Medicinal Chemistry;2024-08